Alzevita

by TOPIA MEDTECH LIMITED  · Based in United Kingdom → — Advancing AI-Powered Brain MRI Analysis
Neurology Radiology

Contact vendor for pricing
Regulatory Status Disclosed

Overview

Alzevita is a cutting-edge, cloud-based AI-powered medical image processing software designed to assist neurologists, radiologists, and imaging labs in the analysis of 3D brain MRI scans. The tool automates hippocampal segmentation and volumetric reporting, providing consistent, quantifiable results from brain MRI scans. This supports objective reporting and helps streamline clinical workflows, enhancing speed, reproducibility, and confidence in neuroimaging.

Alzevita leverages state-of-the-art deep learning techniques, including UNet++ Architecture, ResNet Backbone, and Split Attention Mechanism, to deliver precise segmentation and volumetric analysis of the hippocampus. This innovation is designed to significantly enhance early diagnosis and monitoring of neurodegenerative conditions, such as Alzheimer’s disease, by identifying and quantifying changes in hippocampal structure. It supports industry-standard imaging formats like DICOM and NIFTI, making it interoperable and easy to integrate into existing radiology infrastructures.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-Based Hippocampal Segmentation
  • Quantitative Volumetric Analysis of Brain Structures
  • High Reproducibility and Standardization of Outputs
  • Supports Industry-Standard Imaging Formats (DICOM, NIFTI)
  • Cloud-Based Deployment
  • Assists Neurologists and Radiologists in Diagnosis
  • Supports Objective Reporting
  • Streamlines Clinical Workflows
  • Enhances Diagnostic Confidence
  • Utilizes Advanced Deep Learning Techniques (UNet++, ResNet, Split Attention)

Use Cases

  • Early diagnosis and monitoring of Alzheimer's Disease
  • Assessment of neurodegenerative conditions
  • Automated brain MRI analysis for radiologists and imaging labs
  • Evaluating structural brain changes over time
  • Integration into clinical and research settings
  • Replacing manual hippocampal segmentation workflows

What Physicians Need to Know

Brain MRI/CT Analysis
Alzevita is an AI-powered tool for brain MRI analysis, specifically designed to automate hippocampal segmentation and volumetric reporting. It provides quantitative volume measurements for brain structures and supports industry-standard imaging formats like DICOM and NIFTI. The tool aims to assist radiologists and imaging professionals in analyzing brain MRI scans with precision and consistency, delivering reproducible results to support clinical decision-making in neurological assessments.
Neurodegenerative Disease Screening
Alzevita is intended for the analysis of MRI scans and volumetric measurement of brain regions to aid in the diagnosis of neurodegenerative conditions, such as Alzheimer's Disease. It provides objective and reproducible volumetric assessment, automating hippocampal segmentation and quantification, and offers normative percentile comparisons and longitudinal tracking across serial MRI scans. This can help in detecting subtle structural changes that might be difficult to identify through visual assessment alone, supporting earlier assessment and more informed care planning.
Physician Tip

Alzevita is designed to be a supportive tool for neurologists, radiologists, and researchers, providing quantitative and reproducible data from brain MRI scans. It automates the time-consuming task of hippocampal segmentation, allowing for more efficient workflows and consistent results. Physicians can leverage the volumetric reports, normative comparisons, and longitudinal tracking features to gain objective insights into brain structural changes, which can aid in the early assessment and monitoring of neurodegenerative conditions like Alzheimer's disease. It's important to remember that Alzevita is a clinical decision support tool and does not replace clinical interpretation, diagnosis, or treatment decisions, which should always be made by qualified healthcare professionals.

Alzevita currently operates as a cloud-based system. PACS integration is under development, with future plans to include cloud-based workflows, PACS-integrated transfer and storage, and report access via PACS. The platform supports industry-standard imaging formats, including DICOM and NIFTI, facilitating its integration into existing radiology infrastructure and DICOM workflows.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact vendor for pricing
DeploymentCloud
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-12-19K252670 510(k)Alzevita

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Alzevita

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Alzevita.

Loading videos...

View all on YouTube

Frequently Asked Questions

Alzevita is an AI-powered, cloud-based medical image processing software designed to assist neurologists and radiologists by automating hippocampal segmentation and volumetric brain analysis from 3D brain MRI scans. It integrates into existing radiology and neurology workflows by supporting DICOM and NIfTI formats, providing automated segmentation, quantitative volumetric measurements, and standardized PDF reports for clinical documentation.
Alzevita is FDA Cleared (510(k)-K252670) and CDSCO Approved (MFG/MD/2026/000125), and is currently undergoing regulatory approval for UKCA marking and EU CE certification. It is built for professional use with a focus on compliance, and processes data in alignment with HIPAA/GDPR (optional based on settings).
Alzevita is a clinical decision-support tool and does not detect, diagnose, or predict neurodegeneration; it provides structural data for clinicians to interpret within their clinical decision-making. It cannot independently diagnose Alzheimer's disease from an MRI scan, predict patient outcomes with certainty, or replace the judgment of qualified healthcare professionals.
Alzevita aims to replace manual hippocampal tracing, which is time-consuming, inconsistent, and highly dependent on the operator, with a fast, reproducible, and standardized process. Unlike traditional visual assessment of MRI, which can miss subtle early changes, Alzevita provides objective and reproducible volumetric assessment, enhancing the ability to evaluate early structural patterns. While other AI tools exist for broader neurological conditions or generative AI applications, Alzevita specifically focuses on automated hippocampal segmentation and volumetric analysis.
Alzevita operates on a credit-based system, where one credit corresponds to the analysis of one MRI scan.
Currently, Alzevita focuses on hippocampal segmentation, a key biomarker in neurodegenerative diseases such as Alzheimer's disease. Volumetric reports are typically generated within minutes, depending on scan size and system load.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-14 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.